Abstract
Previous studies have indicated a relationship between bone mineral density and the incidence of breast cancer in middle-aged and elderly women, with women with higher BMD being at significant increased risk. We investigated whether there was such a relationship in younger women who were perimenopausal or in their early postmenopausal years. As part of a population-screening program for osteoporosis, 5,119 women aged between 45 and 54 years were scanned between 1990–1994 at the Osteoporosis Research Unit. In 1997–2001, 3,884 returned for follow-up scans and questionnaires, and 3,144 returned a postal questionnaire in 2002. All cases of incident breast cancer were noted. One hundred sixty-six women indicated that they had suffered from breast cancer, of which 87 were incident cases (59 had prevalent breast cancer at baseline and 20 had benign or unconfirmed diagnosis and were excluded because of the use of agents that may interfere with BMD, e.g., tamoxifen). We compared therefore the incident breast cancer group (BC group; n =87) with a control group (C group; n =3,013). There were no significant differences using a t -test between the BC group and C group for baseline DXA of the spine or femoral neck. Further changes in BMD over a mean period of 6.9 years demonstrated no significant hazard ratio for the lumbar spine or femoral neck. No relationship was seen between the bone turnover markers pyridinoline/creatinine or deoxypyridinoline/creatinine assessed at their second study visit and incidence of breast cancer. In conclusion, in perimenopausal or early postmenopausal women there is no relationship between the incidence of breast cancer and BMD, change in BMD or bone turnover.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buist DS, LaCroix AZ, Barlow WE, White E, Weiss NS (2001) Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol 54:417–422
Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276:1404–1408
Zhang Y, Kiel DP, Kreger BE et al (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336:611–617
van der Klift M, Laet CE, Coebergh JW, Hofman A, Pols HA (2003) Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone 32:211–216
Ganry O, Tramier B, Fardellone P, Raverdy N, Dubreuil A (2001) High bone-mass density as a marker for breast cancer in post-menopausal women. Breast 10:313–317
Nguyen TV, Center JR, Eisman JA (2000) Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 36:27–34
Nelson DA, Darga LL, Simon MS, Severson RK (2004) Radial bone density and breast cancer risk in white and African-American women. Osteoporos Int 15:535–540
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333
Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427
Beral V, Banks E, Reeves G (2002) Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360:942–944
Torgerson DJ (2000) HRT and its impact on the menopause, osteoporosis and breast cancer. Expert Opin Pharmacother 1:1163–1169
Cancer Research UK (2003) Breast cancer fact sheet—June 2003 (web page, accessed 26 November 2003)
Wallace WA, Price VH, Elliot CA, MacPhereson MBA, Scott BW (1990) Hormone replacement therapy acceptability to Nottingham postmenopausal women with a risk factor for osteoporosis. J Roy Soc Med 83:699–701
Oddens BJ, Boulet MJ (1997) Hormone replacement therapy among Danish women aged 45–65 years: prevalence, determinants, and compliance. Obstet Gynecol 90:269–277
Massie A, Reid DM, Porter RW (1993) Screening for osteoporosis: comparison between dual energy X-ray absorptiometry and broadband ultrasound attenuation in 1,000 perimenopausal women. Osteoporos Int 3:107–110
Stewart A, Torgerson DJ, Reid DM (1996) Prediction of fractures in perimenopausal women: a comparison of dual energy X-ray absorptiometry (DXA) and broadband ultrasound attenuation (BUA). Ann Rheum Dis 55:140–142
Torgerson DJ, Garton MJ, Reid DM (1993) Falling and perimenopausal women. Age Ageing 22:59–64
MacDonald HM, McGuigan FA, New SA et al (2001) COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss. J Bone Miner Res 16:1634–1641
Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197–203
MacDonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD (1997) Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 36:50–53
Buist DS, LaCroix AZ, Barlow WE et al (2001) Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States). Cancer Causes Control 12:213–222
Acknowledgments
AS is a United Kingdom Arthritis Research Campaign (arc) Non-Clinical Career Development Fellow. DMR thanks the arc for continuing core support. Thanks are also due to Dr John Harvie for assisting with the hospital record search.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stewart, A., Kumar, V., Torgerson, D.J. et al. Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women. Osteoporos Int 16, 1627–1632 (2005). https://doi.org/10.1007/s00198-005-1886-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-005-1886-4